Murrieta Genomics has announced that its wholly owned subsidiary, SimplSeq Inc., has filed a new patent application for simplified sample... View Article
John Powers, President of Murrieta Genomics and CEO of SimplSeq, our wholly owned subsidiary, was interviewed recently on Beyone with... View Article
Goal is to provide a greater amount of personalized patient data to assist with pharmacogenomic and personalized medicine research
These programs offered by the SBA are a great resource for entrepreneurs in the genomics industry
Genetic testing continues to show an increased impact and improvement of human healthcare. This article outlines the ability to detect... View Article
In a recent post to the American Council on Science and Health, Alex Berezow examines a paper that declares current... View Article